Search - tctmd.com

Displaying 401 - 420 of 861

Sort: Relevancy | Date

Presentation TCT 2014

Updates and Status of the Boston Scientific Vessix Program

Presenter: Deepak L. Bhatt, Michael A. Weber, William A. Gray, Ajay J. Kirtane

September 14, 2014

Presentation TCT 2014

From SYMPLICITY HTN-1 to the Global SYMPLICITY Registry and Beyond: Updates from and Status of the SYMPLICITY Clinical Trial Program

Presenter: Deepak L. Bhatt, Michael A. Weber, William A. Gray, Michael Boehm

September 14, 2014

Presentation TCT 2014

TCT 405: SYMPLICITY HTN-3: Outcomes in the African-American and NonAfrican American Populations

Presenter: Deepak L. Bhatt, Michael A. Weber, William A. Gray, John Flack

September 14, 2014

Presentation TCT 2014

First Deep Dive into SYMPLICITY HTN-3: Primary Results and Updated Analyses

Presenter: Deepak L. Bhatt, Michael A. Weber, William A. Gray

September 14, 2014

Presentation TCT 2014

Postprocedural/Prehemostasis Intraarterial Nitroglycerin: A Prospective, Randomized Trial Evaluating Intrasheath Nitroglycerin to Improve Arterial Patency After Transradial Catheterization

Presenter: Steven R. Bailey, Surya Dharma

September 14, 2014

News Conference News TCT 2014

TCT Keynote: Global Vision for Prevention in Children and Adults Could Change CVD Landscape

September 14, 2014

News Conference News TCT 2014

Post-PCI STEMI Infarct Size Strong Predictor of Mortality, Rehospitalization

September 14, 2014

Presentation TCT 2014

Interatrial Septum Stenting in Idiopathic Pulmonary Hypertension

Presenter: Bagrat Alekyan

September 13, 2014

Presentation TCT 2014

Guidelines and Recommendations for the Practical Application of Renal Denervation Therapies in a Post-SYMPLICITY 3 World

Presenter: Ajay J. Kirtane, Felix Mahfoud, John A. Ormiston, Thomas F. Luscher

September 13, 2014

Presentation TCT 2014

Current Status of Advanced Hypertension Treatment in the United States

Presenter: Ajay J. Kirtane, Felix Mahfoud, John A. Ormiston, Michael A. Weber

September 13, 2014

Presentation TCT 2014

What it Means to Have (and Be) a Hypertension Referral Center

Presenter: Ajay J. Kirtane, Felix Mahfoud, John A. Ormiston, C. Venkata S. Ram

September 13, 2014

Presentation TCT 2014

Workup and Treatment of Hypertension: From A to Z

Presenter: Ajay J. Kirtane, Felix Mahfoud, John A. Ormiston, Atul Pathak

September 13, 2014

Presentation TCT 2014

Essentials of Mapping the Renal Nerves In Vivo

Presenter: Krishna J. Rocha-Singh, Stephen G. Worthley, Robert S. Schwartz, Jie Wang

September 13, 2014

Presentation TCT 2014

Essentials of Chemical Ablation

Presenter: Krishna J. Rocha-Singh, Stephen G. Worthley, Robert S. Schwartz, Tim A. Fischell

September 13, 2014

Presentation TCT 2014

Essentials of Ultrasound Ablation

Presenter: Krishna J. Rocha-Singh, Stephen G. Worthley, Robert S. Schwartz, Joost Daemen

September 13, 2014

Presentation TCT 2014

Essentials of Radiofrequency Ablation (Irrigated and Nonirrigated, Monopolar and Bipolar)

Presenter: Krishna J. Rocha-Singh, Stephen G. Worthley, Robert S. Schwartz, Vivek Y. Reddy

September 13, 2014

Presentation TCT 2014

Next Steps: Translational Opportunities and Methodologies to Get Us Back on Track!

Presenter: Juan F. Granada, Paul A. Sobotka, Farrell O. Mendelsohn

September 13, 2014

Presentation TCT 2014

Does One Size Fit All for Renal Denervation to Work? From Symplicity to Complexity

Presenter: Juan F. Granada, Paul A. Sobotka, Farrell O. Mendelsohn, Felix Mahfoud

September 13, 2014

Presentation TCT 2014

TCT 403: Peripheral Endothelial Function and Sympathetic Influence on Dermal Microcirculation Correlate with Long-term Blood Pressure Response in Renal Denervation Patients

Presenter: Juan F. Granada, Paul A. Sobotka, Farrell O. Mendelsohn, Ulrich Hink

September 13, 2014

Presentation TCT 2014

Preclinical Insights Into the Optimal Ablation Location for Renal Denervation Procedures

Presenter: Juan F. Granada, Paul A. Sobotka, Farrell O. Mendelsohn, Robert J. Melder

September 13, 2014

Advertisement

Updates and Status of the Boston Scientific Vessix Program

From SYMPLICITY HTN-1 to the Global SYMPLICITY Registry and Beyond: Updates from and Status of the SYMPLICITY Clinical Trial Program

TCT 405: SYMPLICITY HTN-3: Outcomes in the African-American and NonAfrican American Populations

First Deep Dive into SYMPLICITY HTN-3: Primary Results and Updated Analyses

Postprocedural/Prehemostasis Intraarterial Nitroglycerin: A Prospective, Randomized Trial Evaluating Intrasheath Nitroglycerin to Improve Arterial Patency After Transradial Catheterization

TCT Keynote: Global Vision for Prevention in Children and Adults Could Change CVD Landscape

Post-PCI STEMI Infarct Size Strong Predictor of Mortality, Rehospitalization

Interatrial Septum Stenting in Idiopathic Pulmonary Hypertension

Guidelines and Recommendations for the Practical Application of Renal Denervation Therapies in a Post-SYMPLICITY 3 World

Current Status of Advanced Hypertension Treatment in the United States

What it Means to Have (and Be) a Hypertension Referral Center

Workup and Treatment of Hypertension: From A to Z

Essentials of Mapping the Renal Nerves In Vivo

Essentials of Chemical Ablation

Essentials of Ultrasound Ablation

Essentials of Radiofrequency Ablation (Irrigated and Nonirrigated, Monopolar and Bipolar)

Next Steps: Translational Opportunities and Methodologies to Get Us Back on Track!

Does One Size Fit All for Renal Denervation to Work? From Symplicity to Complexity

TCT 403: Peripheral Endothelial Function and Sympathetic Influence on Dermal Microcirculation Correlate with Long-term Blood Pressure Response in Renal Denervation Patients

Preclinical Insights Into the Optimal Ablation Location for Renal Denervation Procedures

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content